Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vericel Corporation - Common Stock (NQ:VCEL)

47.02 +0.07 (+0.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 704,815
Open 46.65
Bid (Size) 46.99 (100)
Ask (Size) 47.02 (3,500)
Prev. Close 46.95
Today's Range 46.29 - 47.25
52wk Range 28.95 - 47.79
Shares Outstanding 46,631,158
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests ↗
Focused on regenerative therapies for sports medicine and burn care, this biopharma firm reported a notable insider sale in June. 
Via The Motley Fool
Topics Regulatory Compliance
Vericel Corp (NASDAQ:VCEL): A Classic Affordable Growth Stock in Biotech ↗
Via Chartmill

Performance

YTD
+32.0%
+32.0%
1 Month
+31.5%
+31.5%
3 Month
+41.1%
+41.1%
6 Month
+19.5%
+19.5%
1 Year
+19.3%
+19.3%

More News

Read More
News headline image
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
From Biotech Insider
Via GlobeNewswire
News headline image
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
From World Street Intelligence
Via GlobeNewswire
Vericel Corp (NASDAQ:VCEL): Growth and Technical Setup Align for Potential Breakout ↗
Via Chartmill
Vericel (NASDAQ:VCEL) Balances High Growth and Reasonable Valuation in Affordable Growth Screen ↗
Via Chartmill
Vericel Corp (NASDAQ:VCEL): A Prime Example of Affordable Growth ↗
Via Chartmill
Vericel Corp (NASDAQ:VCEL) Smashes Q1 Estimates, Raises Full-Year Outlook as MACI and Burn Care Surge ↗
Via Chartmill
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Technical Setup Opportunity ↗
Via Chartmill
News headline image
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
MediWound (MDWD) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Vericel Corp (NASDAQ:VCEL) Emerges as a Top Affordable Growth Pick ↗
Via Chartmill
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Breakout Case ↗
Via Chartmill
Vericel Corp (NASDAQ:VCEL) Reports Q4 2025 Earnings In Line, Beats on Profitability ↗
Via Chartmill
News headline image
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
From Energy Metal News
Via GlobeNewswire
News headline image
Vericel Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Vericel (VCEL) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
From MediWound Ltd.
Via GlobeNewswire
News headline image
Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at Multiple Upcoming Investor Conferences
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel (VCEL) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is Vericel Corporation - Common Stock publicly traded?
Yes, Vericel Corporation - Common Stock is publicly traded.
What exchange does Vericel Corporation - Common Stock trade on?
Vericel Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vericel Corporation - Common Stock?
The ticker symbol for Vericel Corporation - Common Stock is VCEL on the Nasdaq Stock Market
What is the current price of Vericel Corporation - Common Stock?
The current price of Vericel Corporation - Common Stock is 47.02
When was Vericel Corporation - Common Stock last traded?
The last trade of Vericel Corporation - Common Stock was at 07/08/26 04:00 PM ET
What is the market capitalization of Vericel Corporation - Common Stock?
The market capitalization of Vericel Corporation - Common Stock is 2.19B
How many shares of Vericel Corporation - Common Stock are outstanding?
Vericel Corporation - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.